研究業績

2011

Papers (English)

 
Original papers


1. Alcalde-Cabero E, Almazán-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, Haybäck J, Höftberger R, Kahana E, Kovacs GG, Ladogana A, Mitrova E, Molesworth A, Nakamura Y, Pocchiari M, Popovic M, Ruiz-Tovar M, Taratuto AL, van Duijn C, Yamada M, Will RG, Zerr I, de Pedro-Cuesta J. Health professions and risk of sporadic Creutzfeldt-Jakob disease. Euro Surveill (In Press)

2. Atarashi R, Satoh K, Sano K, Fuse T, Yamanaka H, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamada M, Mizusawa H, Kitamoto T, McGlade A, Collins SJ, Shirabe S, Katamine S, Nishida N. Ultrasensitive human prion detection in cerebrospinal fluids using real-time quaking-induced conversion. Nat Med 17:175-178, 2011

3. Chen WP, Samuraki M, Shima K, Yanase D, Takeda N, Miyazaki Y, Ono K, Yoshita M,
Nishimura S, Yamada M, Matsunari I. Effect of age and sex mismatched normal database on diagnostic performance of 18F-FDG PET for Alzheimer's disease: The Ishikawa Brain Imaging Study. Nucl Med Commun 32:1128-1133, 2011

4. Fujita K, Harada M, Sasaki M, Yuasa T, Sakai K, Hamaguchi T, Sanjo N, Shiga Y, Satoh K, Atarashi R, Shirabe S, Nagata K, Maeda T, Murayama S, Izumi Y, Kaji R, Yamada M, Mizusawa H. Multicentre multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt-Jakob disease: a reliability and agreement study. BMJ Open (In Press)

5. Furukawa Y, Hamaguchi A, Nozaki I, Iizuka T, Sasagawa T, Shima Y, Demura S, Murakami H, Kawahara N, Okuyama T, Iwasa K, Yamada M. Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccharidosis type I in monozygotic twins with a novel mutation in the alpha-L-iduronidase gene. J Neurol Sci 302:121-125, 2011

6. Furukawa Y, Iwasa K, Ono K, Yamada M. Fisher syndrome associated with immune thrombocytopenic purpura. Intern Med 50:631-633, 2011

7. Furukawa Y, Komai K, Yamada M. Neuromyelitis optica after Japanese encephalitis vaccination. Eur J Neurol 18:e26-e27, 2011

8. Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M. The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol (In Press)

9. Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation. Neurosci Lett 491:48-52, 2011

10. Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M,
Sacco RL, DeCarli C, Wright CB, Elkind MS. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis 216:192-198, 2011

11. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Reply to the Letter by Rizzetti MC, et al. Cobalt toxiciety after total hip replacement: a neglected adverse effect. Muscle Nerve 43:147, 2011

12. Imai T, Tsuda E, Toyoshima T, Yoshikawa H, Motomura M, Shimohama S. Anti-ryanodine receptor-positive acetylcholine receptor-negative myasthenia gravis: evidence of impaired excitation-contraction coupling. Muscle Nerve 43:294-295, 2011

13. Ishida C, Komai K, Yonezawa K, Sakajiri K, Nitta E, Kawashima A, Yamada M. An autopsy case of an aged patient with spinocerebellar ataxia type 2. Neuropathology 31:510-518, 2011

14. Iwasaki K, Kosaka K, Mori H, Okitsu R, Furukawa K, Manabe Y, Yoshita M, Kanamori A, Ito N, Wada K, Kitayama M, Horiguchi J, Yamaguchi S, Fukuhara R, Ouma S, Nakano S, Hashimoto M, Kinoshita T. Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies. J Am Geriatr Soc 59:936-938, 2011

15. Komatsu J, Ono K, Yanase D, Samuraki M, Shima K, Kuwano R, Matsunari I, Yamada M. Imaging findings of familial dementia with a tau R406W mutation. Acta Neurol Belg 111:374-375, 2011

16. Miyasaka N, Hara M, Koike T, Saito E, Yamada M, Tanaka Y. Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial. Mod Rhematol (In Press)

17. Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M. Effects of sex hormones on Alzheimer’s disease-associated β-amyloid oligomer formation in vitro. Exp Neurol 228:298-302, 2011

18. Murai H, Yamashita N, Watanabe M, Nomura Y, Motomura M, Yoshikawa H, Nakamura Y, Kawaguchi N, Onodera H, Araga S, Isobe N, Nagai M, Kira J. Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 305:97-102, 2011

19. Nagoshi K, Sadakane Y, Nakamura Y, Yamada M, Mizusawa H. Duration of prion diseases in Japan is longer than that in other countires. J Epidemiol 21:255-262, 2011

20. Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, Kinuya S. Standardization of metaiodobenzylguanidine heart-to-mediastinum ratio using a calibration phantom: Effects of correction on normal dabtabases and a multi-center study. Eur J Nucl Med Mol Imaging (In Press)

21. Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Sakai K, Yamada M. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease. J Neurol 258:1464-1468, 2011

22. Nozaki I, Sakai K, Kitamoto T, Yamada M. Prion protein gene M232R mutation as a cause of genetic prion disease (Reply to the Letter to the Editor: Beck et al. Prion protein gene M232R variation is probably uncommon polymorphism rather than a cause of inherited prion disease.) Brain, published on line : November 16, e1-e2, 2011

23. Nozaki I, Yamada M. An easy diagnositic tool distinguishing lateral medullary infarction from peripheral vertigo. Clin Neurol Neurosurg (In Press)

24. Ono K, Ikeda T, Takasaki J, Yamada M. Familial Parkinson disease mutations influence α-synuclein assembly. Neurobiol Dis 43:715-724, 2011

25. Ono K, Mochizuki H, Ikeda T, Nihira T, Takasaki J, Teplow DB, Yamada M. Effect of melatonin on α-synuclein self-assembly and cytotoxicity. Neurobiol Aging (In Press)

26. Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, Levine H 3rd, Jucker M, Walker LC. Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rat. J Neurochem (In Press)

27. Sakai K, Hayashi S, Sanpei K, Yamada M, Takahashi H. Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy related inflammation. Neuropathology (In Press)

28. Sakai K, Ono K, Harada H, Shima K, Notoya M, Yamada M. Parkinson’s disease showing progressive conduction aphasia. Neurol Sci (In Press)

29. Sakai K, Ono K, Okamoto Y, Murakami H, Yamada M. Cervical flexion myelopathy in a patient showing apparent long tract signs: a severe form of Hirayama disease. Joint Bone Spine 78:316-318, 2011

30. Sakai K, Yamada M. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra. Neuropathology 31:77-81, 2011

31. Sakai K, Yoshita M, Samuraki M, Yamada M. Acute disseminated encephalomyelitis with medial temporal lesions mimicking acute limbic encephalitis. Clin Neurol Neurosurg 113:72-74, 2011

32. Samuraki M, Matsunari I, Chen WP, Shima K, Yanase D, Takeda N, Matsuda H, Yamada M. Glucose Metabolism and Gray-matter Concentration in Apolipoprotein E Ԑ4 Positive Normal Subjects. Neurobiol Aging (In Press)

33. Shima K, Matsunari I, Samuaki M, Chen WP, Yanase D, Noguchi-Shinohara M, Takeda N,
Ono K, Yoshita M, Miyazaki Y, Matsuda H, Yamada M. Posterior cingulate atrophy and metabolic decline in early stage Alzheimer’s disease. Neurobiol Aging (In Press)

34. Sugano K, Yokogawa M, Yuki S, Dohmoto C, Yoshita M, Hamaguchi T, Yanase D, Iwasa K, Komai K, Yamada M. Effect of cognitive and aerobic training intervention for older adults with mild or no cognitive impairment: a derivative study of the Nakajima Project. Dement Geriat Cogn Disord Extra (In Press)

35. Suzuki S, Utsugisawa K, Iwasa K, Satoh T, Nagane Y, Yoshikawa H, Kuwana M, Suzuki N. Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis. J Neuroimmunol 237:87-92, 2011

36. Takahashi R, Ikeda T, Hamaguchi A, Iwasa K, Yamada M. Coenzyme Q10 therapy in hereditary motor sensory neuropathy type VI with novel mitofusin 2 mutation. Intern Med (In Press)

37. Takasaki J, Ono K, Yoshiike Y, Hirohata M, Ikeda T, Morinaga A, Takashima A, Yamada M. Vitamin A has anti-oligomerization effects on amyloid-β in vitro. J Alzheimers Dis 27:271-280, 2011

38. Wang J, Ono K, Dickstein D, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Ferruzzi MG, Pavlides C, Ho L, Hof P, Teplow DB, Pasinetti GM. Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiol Aging 32:2321-2333, 2011

39. Willey JZ, Moon YP, Paik MC, Yoshita M, Decarli C, Sacco RL, Elkind MS, Wright CB. Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology 76:2112-2118, 2011

40. Yoshikawa H, Kiuchi T, Saida T, Takamori M. Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis. J Neurol Neurosurg Psychiatry 82:970-977, 2011

41. Yoshikawa Y, Horiuchi M, Ishigura N, Kadohira M, Kai S, Mizusawa H, Nagata C, Onodera T, Sata T, Tsutsui T, Yamada M, Yamamoto S. Alternative BSE risk assessment methodology of imported beef and beef offal to Japan. J Vet Med Sci (In Press)
 
Reviews


1. Ono K, Yamada M. Low-n oligomers as therapeutic targets of Alzheimer’s disease. J Neurochem 117:19-28, 2011

2. Ono K, Yamada M. Vitamin A and Alzheimer’s disease. Geriatr Gerontol Int (In Press)

3. Yamada M, Naiki H. Cerebral amyloid anigopathy. Prog Mol Biol Transl Sci (In Press)
 
 

Presentations (International meeting)

 
Invited lectures


1. Ono K. Low-n oligomers as therapeutic targets of Alzheimer’s disease. Neuroscience Seminar in University of Groningen, Groningen, July 15, 2011

2. Yamada M, Sakai K, Nozaki I, Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Kitamoto T, Sanjo N, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Inuzuka T, Takeda M, Abe K, Murai H, Murayama S, Tateishi J, Shirabe S, Takumi I, Harada M, Mizusawa H. Prion disease in Japan. Asian Pacific Prion Symposium 2011, Karuizawa, July 10-11, 2011
 
Presentations


1. Akagi A, Iwasa K, Sakai K, Motozaki Y, Ono K, Sugiyama Y, Yamada M. A unique familial amyloid polyneuropathy family with a transthyretin Leu58Arg mutation. VIIIth International Syposium on Familial Amyloidotic Polyneuropathy, Kumamoto, November 20-22, 2011

2. Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Cerebrospinal fluid from patients with α-synucleinopathies promotes in vitro α-synuclein fibril formation. Alzheimer’s Association International Conference on Alzheimer’s Disease 2011, Paris, July 16-21, 2011

3. Ikeda T, Ono K, Condron M, Noguchi-Shinohara M, Yoshita M, Teplow D, Yamada M. Effect of cerebrospinal fluid in Alzheimer patients on amyloid β-protein oligomerization. Alzheimer’s Association International Conference on Alzheimer’s Disease 2011, Paris, July 16-21, 2011

4. Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Matsunari I, Yamada M. A comparison of the diagnostic sensitivity for Alzheimer’s disease among MRI, ECD-SPECT, FDG-PET, and cerebrospinal fluid biomarkers in a memory clinic. Alzheimer’s Association International Conference on Alzheimer’s Disease 2011, Paris, July 16-21, 2011

5. Nakajima K, Okuda K, Matsuo S, Kirihara Y, Ishikawa T, Taki J, Yoshita M, Yamada M, Kinuya S. Standardization of cardiac metaiodobenzylguanidine (MIBG) heart-to-mediastinum (H/M) ratio for a multicenter study: Utiliyy of inter-institutional calibration phantoms. ICNC10-Nuclear Cardiology and Cardiac CT, Amsterdam, May 15-18, 2011

6. Ono K, Mochizuki H, Ikeda T, Nihira T, Takasaki J, Teplow DB, Yamada M. Effect of melatonin on α-synuclein self-assembly and cytotoxicity. Alzheimer’s Association International Conference on Alzheimer’s Disease 2011, Paris, July 16-21, 2011

7. Sakai K, Nozaki I, Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Kitamoto T, Mizusawa H, Sanjo N, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Inuzuka T, Takeda M, Abe K, Murai H, Murayama S, Tateishi J, Shirabe S, Takumi I, Harada M, Yamada M. Human prion diseases in Japan: a prospective surveillance from 1999. Asian Pacific prion Symposium 2011, Karuizawa, July 10-11, 2011

8. Yamada M, Sanjo N, Murayama S, Takeda M, Kuzuhara S, Abe K, Noguchi-Shinohara M, Sakai K, Nozaki I, Mizusawa H, Hamaguchi T, Sadakane A, Nakamura Y, Sato T, Kitamoto T, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Inuzuka T, Kuroda S, Murai H, Tateishi J, Takumi I, Shirabe S, Harada M. Human prion disease in Japan: Analysis of 1552 patients in a prospective 11-year surveillance. Alzheimer’s Association International Conference on Alzheimer’s Disease 2011, Paris, July 16-21, 2011
 
TOPへ戻る